David D. Chang - President and CEO, Director at Allogene Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Stock Symbol
ALLO on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by David D. Chang since 11/23/2023

Holdings reported by David D. Chang for Allogene Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 4.81M $13.9M $2.90 May 16, 2024 Direct
Common Stock 856K $2.48M $2.90 May 16, 2024 Indirect
Stock Option (Right to buy) 1.12M Jan 25, 2024 Direct Common Stock

Transactions reported by David D. Chang for Allogene Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.